Brainstorm Decides Not to Offer Investigational ALS Therapy NurOwn Under Right to Try Law

ProMIS Moving into 2nd Phase of Work on Antibody Treatment for ALS

ProMIS Neurosciences announced that it is moving toward selecting antibodies — from the many identified in earlier work — that specifically target the toxic proteins that accumulate in the brains of amyotrophic lateral sclerosis (ALS) and Alzheimer’s patients, and that may work as therapies. Specifically for ALS, the identified antibodies target TDP43…

ALS Is No Laughing Matter but a Little Humor Helps

Having ALS is certainly no laughing matter, but I’ve found that living with it can give rise to many humorous moments. Most of my “laugh out loud” episodes are the result of misunderstood conversations, encounters with Murphy’s Law, or while attempting to open “tamper-proof” pill bottles. I’ll…

Keeping the Faith

ALS has been a blessing to me. You read that right — a blessing. Oh, it has been many other things: ordeal, handicap, curse, millstone, scene-stealer, tormentor, humiliator, predator, interloper, income garnisher, bully, danger, satirist, infidel, and terrorist. It strives, ultimately, to be my terminator. But, if not for ALS,…